National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 5,536 cases where Vaccine targets COVID-19 (COVID19) and Manufacturer is PFIZER/BIONTECH and Symptom is Myocarditis

Government Disclaimer on use of this data



Case Details

This is page 18 out of 554

Result pages: prev   9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27   next


VAERS ID: 1326155 (history)  
Form: Version 2.0  
Age: 21.0  
Sex: Male  
Location: California  
Vaccinated:2021-04-29
Onset:2021-05-01
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Myocarditis, Pericarditis
SMQs:, Systemic lupus erythematosus (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: PFIZER INC2021494277

Write-up: acute myocarditis; Pericarditis; This is a spontaneous report from a contactable a physician. A 21-year-old male patient started to receive 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, LOT/Batch number and expiration date unknown) via an unspecified route of administration on 29Apr2021 at age of 21-year-old at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient previously received 1st dose of BNT162B2 on an unspecified date for COVID-19 immunization. Prior to vaccination, the patient wasn''t diagnosed with COVID-19. Since the vaccination, the patient hasn''t been tested for COVID-19. Acute myocarditis/pericarditis started on 01May2021, 2 days post vaccination, diagnosed on 03May2021, 4 days post vaccination (second dose vaccine). The events resulted in emergency room/department or urgent care visit. Events were serious as hospitalization. Patient received anti inflammatory medications for the events. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender''s Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.


VAERS ID: 1326167 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Massachusetts  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Myocarditis
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021495809

Write-up: myocarditis; This is a spontaneous report from a non-contactable other HCP via a Pfizer sales representative. A 28-year-old patient of an unspecified gender received second dose of BNT162B2 (Lot Number: Unknown) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. Unknown if diagnosed with COVID-19 prior vaccination, and unknown if COVID-19 tested post vaccination. The patient was diagnosed with myocarditis following second dose vaccine on unknown date. Event resulted in doctor or other healthcare professional office/clinic visit. The patient was seen at a Medical Center for treatment and diagnosis. The outcome of event was unknown. Information on the lot/batch number has been requested.; Sender''s Comments: Based on the information provided, A possible contributory role of the suspect product to the development of Myocarditis cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.


VAERS ID: 1326721 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: New Jersey  
Vaccinated:2021-05-13
Onset:2021-05-15
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8731 / 2 LA / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Blood creatine phosphokinase MB, Blood creatine phosphokinase decreased, Blood creatine phosphokinase increased, C-reactive protein increased, Chest pain, Chills, Echocardiogram abnormal, Electrocardiogram ST-T change, Electrocardiogram normal, Fatigue, Intensive care, Myocarditis, Pain, Pyrexia, Red blood cell sedimentation rate normal, Respiratory viral panel, SARS-CoV-2 antibody test positive, Troponin increased, Ventricular dyskinesia, Ventricular hypokinesia
SMQs:, Rhabdomyolysis/myopathy (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Afrin nasal spray 2 pumps to each nostril every other day.
Current Illness: Congestion and runny nose. Denies fevers, nausea, vomiting, diarrhea, rashes, sick contacts, coughing, wheezing.
Preexisting Conditions: None.
Allergies: No food allergies, no medication allergies. (+) pollen allergies.
Diagnostic Lab Data: Patient is a 17-year-old male with no significant past medical history who presents with 1 day of sudden onset sharp chest pain, found to have diffuse ST elevation on EKG as well as elevated troponin consistent with acute myopericarditis. Must consider whether presentation is related to patient having received his 2nd COVID-19 vaccine 2 days prior to presentation. COVID-19 spike protein antibodies are positive but no evidence of prior infection. However, will also evaluate possible viral causes for the myopericardial inflammation. Patient is currently hemodynamically stable but admitted to the PICU for telemetry due to risk for dysrythmia given myocardial inflammation. Working dx of myopericarditis secondary to possible COVID vaccine. #CV - Continue indomethacin 50mg TID - EKG from this AM: NSR with ST/T changes - ECHO: mild left ventricular apical dyskinesis (left ventricular systolic function borderline low with decreased wall excursion at apex with good RV systolic function and no significant pericardial effusion). -- Repeat ECHO today: globally borderline mildly depressed systolic function with mild hypokinesis as the ventricular apex. No significant pericardial effusion. Stable findings from ECHO 5/16/21. - Troponin elevated to 1.63 $g 1.72 $g 1.75 $g 2.52 - CKMB: 109.1 (0-6.3) -- Ratio 14.4% (0-3.9%) - CPK: 759 - Cardio on consult -- recommends daily trending of labs - Qday ECGs ++ when pt clinically is symptomatic - Monitor for signs for clinical worsening #ID - COVID-19 spike protein Ab: (+), COVID-19 Nucleocapsid Ab: (-) - Obtain workup for viral myocarditis (CMV, EBV, adenovirus, enterovirus, coxsackievirus, adenovirus, Parvo B19) -- F/u results - RVP: negative - ESR 14 $g 15 - CRP 8.12 $g 6.54 - ID on consult -- recommends the MISC lab workup for possible MISC vs. adverse reaction to vaccine (CBC, CMP, BNP, COVID PCR, COVID Ab, ESR, CRP, BCx, UA, UCx, fibrinogen, PT/PTT, D-dimer, Ferritin, Procalcitonin, LDH, VBG (iCal, lactate), troponin, CPK). #FEN/GI - Regular diet - Pepcid 20mg BID
CDC Split Type:

Write-up: 5/14/21 - day 1 after vaccine dose #2 - had fevers, body aches, chills, fatigue. 5/15/21 - day 2 after vaccine dose #2 - began to have chest pain that started out at 5/10 and then became constant and persistent sharp, 10/10 chest pain that was worse with lying back and improved with sitting up and leaning forward. Pt went to Urgent Care, had ECG done and demonstrated ST wave changes where he was brought to ED and ECG confirmed ST/T wave changes and Troponin T was elevated to 1.62 - thus with these findings and the chest pain that was consistent with pericarditis - diagnosis of myopericarditis was made.


VAERS ID: 1327087 (history)  
Form: Version 2.0  
Age: 18.0  
Sex: Male  
Location: Arkansas  
Vaccinated:2021-04-30
Onset:2021-05-02
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8731 / 2 RA / SYR

Administered by: Work       Purchased by: ?
Symptoms: Chest pain, Dyspnoea, Myocardial infarction, Myocarditis
SMQs:, Anaphylactic reaction (broad), Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: He had chest pains and could not breath after 48 hours, rushed to the ER. Stayed in the hospital for 4 days. He had a heart attack and was diagnosed with acute idiopathic myocarditis.


VAERS ID: 1327432 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: Maryland  
Vaccinated:2021-05-12
Onset:2021-05-14
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Alanine aminotransferase increased, Arthralgia, Aspartate aminotransferase increased, Blood albumin normal, Blood alkaline phosphatase normal, Blood bilirubin normal, Blood calcium increased, Blood chloride normal, Blood creatinine increased, Blood glucose normal, Blood potassium normal, Blood sodium normal, Blood test, Blood urea normal, C-reactive protein increased, Carbon dioxide normal, Cardiac monitoring normal, Chest X-ray normal, Chest pain, Chills, Cytomegalovirus test negative, Dyspnoea, Echocardiogram normal, Electrocardiogram ST segment elevation, Epstein-Barr virus antibody positive, Haematocrit normal, Haemoglobin normal, Inflammation, Magnetic resonance imaging normal, Myocarditis, N-terminal prohormone brain natriuretic peptide increased, Pain, Painful respiration, Platelet count decreased, Protein total normal, Red blood cell count decreased, Red blood cell sedimentation rate increased, SARS-CoV-2 test negative, Tachycardia, Troponin increased, White blood cell count increased
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (broad), Cardiac failure (broad), Liver related investigations, signs and symptoms (narrow), Anaphylactic reaction (broad), Haematopoietic erythropenia (narrow), Haematopoietic thrombocytopenia (narrow), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Retroperitoneal fibrosis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Arthritis (broad), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: Hematocrit 43.4 (5/15/2021) Hemoglobin 15.2 (5/15/2021) Platelets 148 (5/15/2021) RBC 4.76 (5/15/2021) WBC 12.83* (5/15/2021) Albumin 4.3 (5/15/2021) Alk Phos 90 (5/15/2021) ALT 56* (5/15/2021) AST 53* (5/15/2021) Bilirubin Total 0.6 (5/15/2021) BUN 13 (5/15/2021) Calcium 9.8 (5/15/2021) Chloride 100 (5/15/2021) CO2 26 (5/15/2021) Creatinine 0.97 (5/15/2021) Glucose Bld 110* (5/15/2021) Potassium 4.1 (5/15/2021) Sodium 137 (5/15/2021) Total Protein 7.6 (5/15/2021) 5/17/2021: Cardiac MRI "Normal biventricular size and function. No evidence of pericarditis. Minimal mid wall enhancement in the inferolateral and lateral left ventricular walls could reflect minimal/resolving inflammation/myocarditis given this patient''s clinical presentation. Repeat cardiac MRI can be considered in 1-3 months." 5/16/2021: Echocardiogram "Technically difficult, suboptimal study. No pericardial effusion. Normal left ventricular systolic function. Normal right ventricular systolic function. Echobright septum."
CDC Split Type:

Write-up: 17 y.o. male who presents with chest pain, elevated troponins and diffuse ST elevations concerning for pericarditis vs myocarditis admitted for cardiac monitoring and evaluation. Pt states he has had 1 day of sudden onset L shoulder pain and chest pain. Endorses dyspnea due to pain with deep breaths, denies tachypnea, nausea/vomiting, diaphoresis. Endorses mild chills and aches after COVID vaccine 3 days prior to onset of symptoms, denies any fever, URI symptoms, diarrhea, rash, known COVID contacts. Pain continued to worsen and spread across his chest, causing presentation to ED this afternoon. No history of PE, DVT, long travel, recent surgery, malignancy, alcohol or cocaine use. Significant cardiac history in family: dad with CAD w/LAD blockage, both parents with hypertension. At ED, labs notable for elevated troponin 0.456, repeat 0.67 and diffuse ST elevations on EKG concerning for pericarditis. COVID neg, CXR unremarkable, blood cx drawn, no abx started. Patient was given toradol for pain with minimal improvement. Peds cardiology was consulted and patient was transferred to different ED for further care. At different ED, repeat EKG showed similar diffuse ST elevations in I, II, aVL. Repeat troponins uptrending (4.91), proBNP 562, ESR 43, CRP 18. Mildly tachycardic but otherwise hemodynamically stable. Given tylenol for pain. Cardiology recommended admission for trending troponins, echo and cardiac monitoring. CV: Troponins were trended every 12 hours with a max of 4.91. His last troponin checked on the morning of discharge was 0.41. He had an echo that showed normal cardiac function, an MRI that indicated normal ventricular size and function, with minimal or healing and inflammation or mild myocarditis. During his admission, he had continuous cardiorespiratory monitoring, that did not show any arrhythmias. Resp: On 2L NC for comfort, no respiratory distress or hypoxia. FENGI: Regular diet Neuro: Ibuprofen scheduled and tylenol PRN for pain. He was initially started on ibuprofen 800 mg every 8 hours, but was starting to have pain prior to being due for medicine every 8 hours so his regimen was changed to 600 mg every 6 hours which controlled his pain adequately. ID: Myocarditis panel sent with some results still pending. Thus far, he is CMV negative, EBV IgG was positive but not IgM. RVP was negative. This all occurred in the setting receiving the Covid vaccine 3 days prior to presentation, which has been reported as a rare reaction to the Covid vaccine. At the time of discharge, labs pending results include mycoplasma pneumonia, coxsackie, parvovirus, enterovirus. Etiology of myocarditis remains unclear at this time, could be related to infectious etiology not yet clear to us, vs related to his COVID vaccine prior to admission.


VAERS ID: 1327805 (history)  
Form: Version 2.0  
Age: 21.0  
Sex: Male  
Location: Washington  
Vaccinated:2021-05-16
Onset:2021-05-17
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Myocarditis, Troponin increased
SMQs:, Myocardial infarction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: Troponin 3.5
CDC Split Type:

Write-up: Myocarditis with elevated Troponin and chest pain the day after vaccination


VAERS ID: 1328253 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: California  
Vaccinated:2021-05-15
Onset:2021-05-17
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 UN / SYR

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Echocardiogram, Electrocardiogram, Electrocardiogram ST segment elevation, Myocarditis, Troponin increased
SMQs:, Myocardial infarction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None known allergies
Diagnostic Lab Data: EKG 5/18 diffuse ST elevation ECHO 5/18 normal Troponin 5/18 17540
CDC Split Type:

Write-up: Developed chest pain and diagnosed with myopericarditis based on EKG and elevated troponins. admitted for monitoring


VAERS ID: 1328759 (history)  
Form: Version 2.0  
Age: 27.0  
Sex: Male  
Location: Washington  
Vaccinated:2021-05-14
Onset:2021-05-15
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8736 / 2 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Cardiac imaging procedure abnormal, Myocarditis, Troponin increased
SMQs:, Myocardial infarction (narrow), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ibuprofen
Current Illness:
Preexisting Conditions: GERD anxiety scoliosis
Allergies: gramineae pollens
Diagnostic Lab Data: MRI cardiac morph with and without IV contrast Result Date: 5/17/2021 1. There is MRI evidence to support very mild regional myopericarditis as detailed above. 2. No significant pericardial effusion. 3. Biventricular ejection fractions are within normal limits. 4. Biventricular end diastolic volumes are mildly depressed. Exam images have been permanently archived. Troponin peak measurement 6.42 5/16/2021.
CDC Split Type:

Write-up: Myopericarditis as demonstrated on cardiac MRI.


VAERS ID: 1391879 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: Minnesota  
Vaccinated:2021-05-11
Onset:2021-05-15
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0167 / 2 AR / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Chest pain, Electrocardiogram ST segment elevation, Electrocardiogram abnormal, Myalgia, Myocarditis, Neck pain, Pharyngeal swelling, Sinusitis, Troponin
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Angioedema (narrow), Myocardial infarction (broad), Arrhythmia related investigations, signs and symptoms (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (narrow), Arthritis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Methylphenidate, albuterol, Symbicort, Bactrim, fluoxetine
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Serial troponin checks- 5/15-5/18, Peak troponin 25.2 EKG- 5/15-5/17, Diffuse St segment elevations Cardiac MRI scheduled for 5/19
CDC Split Type:

Write-up: Presented on 5/15 with chest pain and diffuse ST segment elevation consistent with perimyocarditis. He received his second COVID vaccine (5/11) 4 days ago- reports 3 days ago feeling sinus inflammation, throat felt swollen, and laid in bed all day, 2 days ago- he reports just having sinus inflammation sensation, 5/10- he reports feeling like every muscle including his neck hurt. No headache, vision changes, weakness, tingling. No cardiac history, leg swelling, rash, rhinorrhea, or recent illness.


VAERS ID: 1329571 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-05-07
Onset:2021-05-08
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW 0171 / 2 LA / -

Administered by: Public       Purchased by: ?
Symptoms: Blood test, Chest X-ray, Chest pain, Echocardiogram, Electrocardiogram, Full blood count, Investigation, Myocarditis, SARS-CoV-2 test, Troponin
SMQs:, Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Sulfonamide allergy (Known allergies: Sulfa)
Allergies:
Diagnostic Lab Data: Test Name: several blood works; Result Unstructured Data: Test Result:Unknown results; Test Name: chest x-rays; Result Unstructured Data: Test Result:Unknown results; Comments: three times; Test Name: cardiac ultrasounds; Result Unstructured Data: Test Result:Unknown results; Test Name: EKGs and ECGs; Result Unstructured Data: Test Result:Unknown results; Test Date: 2020; Test Name: full work up; Result Unstructured Data: Test Result:Normal; Comments: Had full work up less than a year ago and everything came back completely normal.; Test Name: nuclear cardiac wall motion test or some kind of nuclear test; Result Unstructured Data: Test Result:Unknown results; Comments: unsure of the name: nuclear cardiac wall motion test or some kind of nuclear test; Test Date: 20210511; Test Name: Nasal Swab; Test Result: Negative ; Test Name: troponin levels; Result Unstructured Data: Test Result:Critical; Comments: heart enzyme
CDC Split Type: USPFIZER INC2021530833

Write-up: myocarditis; Chest pain; This is a spontaneous report from two contactable consumers (one is patient himself and the other one is patient''s wife). A 35-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 07May2021 15:30 (Batch/Lot Number: EW 0171; Expiration Date: Aug2021) as 2nd dose, single for covid-19 immunisation, at a public Health Department. The vaccine was not administered at Military Facility. No additional Vaccines Administered on Same Date of the Pfizer Suspect. The patient''s medical history included known allergies: Sulfa. No family Medical History Relevant to events. There were no concomitant medications. There was no other products. The patient did not receive any other medications within 2 weeks of vaccination. For historical vaccine, there was no prior vaccinations within 4 weeks aside from first dose: bnt162b2, dose 1 intramuscular administered in Arm Left on 16Apr2021 15:30 (Batch/Lot Number: ER 8737; Expiration Date: Aug2021) (at the age of 35-year-old) as 1st dose, single for covid-19 immunisation. The facility of vaccination was Other no AE. On 08May2021 02:00, the patient experienced chest pain. The event chest pain resulted in Emergency room/department or urgent care, hospitalization, and was life threatening illness (immediate risk of death from the event). On 13May2021, the patient''s wife reported that her husband was in the hospital with myocarditis onset from 11May2021(also reported as three days after receiving his second dose of the vaccine). The patient was admitted to the hospital at 02:00 on Tuesday 11May2021, he was still in the hospital by the time of reporting. Also reported that the event myocarditis required Emergency Room visit. A lot of testing were done such as cardiac ultrasounds, several electrocardiogram (EKG)s and electrocardiogram (ECG)s, nuclear cardiac wall motion test or some kind of nuclear test she is unsure of the name, chest x-rays three times, several blood works, his troponin levels (heart enzyme) was critical. The patient did not have COVID prior to vaccination. The patient had been tested post vaccination, COVID test type post vaccination was Nasal Swab on 11May2021, result was Negative. The patient had full work up less than a year ago and everything came back completely normal (In 2020). Therapeutic measures were taken as a result of events chest pain and myocarditis. The patient was treated with medication and he had to get a wearable defibrillator called Life Vest. They have him on a blood thinner, carvedilol, and entresto. The outcome of the events was not recovered.


Result pages: prev   9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=18&SYMPTOMS=Myocarditis_%2810028606%29&VAX=COVID19&VAXTYPES=COVID-19&VAXMAN=PFIZER/BIONTECH


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166